Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen
K Aoyagi, C Ohue, K Iida, T Kimura… - Journal of clinical …, 1999 - Am Soc Microbiol
A highly sensitive enzyme immunoassay (EIA) for the hepatitis C virus (HCV) core antigen (HCVcAg)
was developed, and its performance was compared with that of the AMPLICOR …
was developed, and its performance was compared with that of the AMPLICOR …
Clinical efficacy of a novel, high-sensitivity HBcrAg assay in the management of chronic hepatitis B and HBV reactivation
…, T Suzuki, S Yagi, A Kaneko, K Matsuura, K Aoyagi… - Journal of …, 2021 - Elsevier
Background & Aims A fully automated, novel high-sensitivity hepatitis B core-related antigen
assay (iTACT-HBcrAg) has been developed. We demonstrate the clinical utility of iTACT-…
assay (iTACT-HBcrAg) has been developed. We demonstrate the clinical utility of iTACT-…
Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA
E Tanaka, C Ohue, K Aoyagi, K Yamaguchi, S Yagi… - Hepatology, 2000 - Elsevier
The aim of this study was to analyze the clinical performance of a new enzyme immunoassay
(EIA) for hepatitis C virus (HCV) core antigen in comparison with the reverse transcription …
(EIA) for hepatitis C virus (HCV) core antigen in comparison with the reverse transcription …
[PDF][PDF] Rapid point-of-care test for hepatitis B core-related antigen to diagnose high viral load in resource-limited settings
Y Shimakawa, G Ndow, A Kaneko, K Aoyagi… - Clinical …, 2023 - Elsevier
… Yusuke Shimakawa,1,2 Gibril Ndow,3,4 Atsushi Kaneko,5 Katsumi Aoyagi,5 Maud
Lemoine,4 Yasuhito Tanaka,6 and PROLIFICA/HBcrAg-RDT Study Group …
Lemoine,4 Yasuhito Tanaka,6 and PROLIFICA/HBcrAg-RDT Study Group …
Hepatitis B core-related antigen: An alternative to hepatitis B virus DNA to assess treatment eligibility in Africa
…, M Imaizumi, K Moriyama, K Aoyagi… - Clinical Infectious …, 2020 - academic.oup.com
Background To eliminate hepatitis B virus (HBV) infection, it is essential to scale up testing
and treatment. However, conventional tools to assess treatment eligibility, particularly nucleic …
and treatment. However, conventional tools to assess treatment eligibility, particularly nucleic …
Clinical usefulness of a novel high-sensitivity hepatitis B core-related antigen assay to determine the initiation of treatment for HBV reactivation
…, A Kaneko, K Fujiwara, T Watanabe, K Aoyagi… - Journal of …, 2022 - Springer
Backgrounds A fully automated, novel, high-sensitivity hepatitis B core-related antigen assay
(iTACT-HBcrAg) has been developing. The purpose of this study is to evaluate the efficacy …
(iTACT-HBcrAg) has been developing. The purpose of this study is to evaluate the efficacy …
Enzyme immunoassay of immunoreactive progastrin-releasing peptide (31-98) as tumor marker for small-cell lung carcinoma: development and evaluation
K Aoyagi, Y Miyake, K Urakami… - Clinical …, 1995 - academic.oup.com
Previously, using recombinant human progastrin-releasing peptide (ProGRP)(31-98), we
developed a RIA for ProGRP(31-98) and demonstrated that the determination of serum ProGRP…
developed a RIA for ProGRP(31-98) and demonstrated that the determination of serum ProGRP…
Management of hepatitis B virus (HBV) reactivation in patients with resolved HBV infection based on a highly sensitive HB core‐related antigen assay
…, K Matsuura, S Yagi, A Kaneko, K Aoyagi… - Hepatology …, 2022 - Wiley Online Library
Aims To prevent hepatitis B virus (HBV) reactivation‐related hepatitis, we examined the
clinical usefulness of a highly sensitive HB core‐related antigen (iTACT‐HBcrAg) assay in …
clinical usefulness of a highly sensitive HB core‐related antigen (iTACT‐HBcrAg) assay in …
Immunochromatographic test for the detection of SARS-CoV-2 in saliva
…, T Maeda, T Miyazaki, S Yoshizawa, K Aoyagi… - Journal of Infection and …, 2021 - Elsevier
We evaluated the rapid immunochromatographic test for severe acute respiratory coronavirus
2 (SARS-CoV-2) antigen detection using 16 saliva specimens collected from 6 COVID-19 …
2 (SARS-CoV-2) antigen detection using 16 saliva specimens collected from 6 COVID-19 …
Enzyme‐linked immunosorbent assay of pro‐gastrin‐releasing peptide for small cell lung cancer patients in comparison with neuron‐specific enolase measurement
K Yamaguchi, K Aoyagi, K Urakami… - Japanese journal of …, 1995 - Wiley Online Library
Our previous study demonstrated that pro‐gastrin‐releasing peptide(31–98), or ProGRP, is
a specific tumor marker in patients with small cell lung carcinoma (SCLC). Using a newly …
a specific tumor marker in patients with small cell lung carcinoma (SCLC). Using a newly …
